GeoPharma Financial Statements
GeoPharma Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | March |
This data is provided as per license from EDGAR Online
GeoPharma Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 55.0 | 59.8 | 49.7 |
| Gross Profit ($ mil.) | 10.9 | 16.9 | 12.5 |
| Operating Income ($ mil.) | (9.9) | 1.3 | 2.0 |
| Total Net Income ($ mil.) | (7.0) | 2.5 | 1.8 |
| Diluted EPS (Net Income) | (0.59) | 0.19 | 0.14 |
GeoPharma Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 20.0 | 23.9 | 18.2 |
| Gross Profit ($ mil.) | 3.7 | 4.6 | 3.6 |
| Operating Income ($ mil.) | (3.0) | (2.8) | (2.3) |
| Total Net Income ($ mil.) | (2.6) | (2.7) | (1.6) |
| Diluted EPS (Net Income) | (0.19) | (0.20) | (0.12) |
GeoPharma Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 0.62 | 3.68 | 1.55 |
| Price/Earnings Ratio | -- | 15.08 | 15.52 |
| Price/Book Ratio | 1.07 | 2.95 | 1.48 |
| Price/Cash Flow Ratio | -- | 12.46 | 9.60 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed GeoPharma Financial Ratios
GeoPharma Competitive Intelligence
| NAI | NBTY | Nexgen | |
|---|---|---|---|
| Annual Sales ($ mil.) | 97.1 | 2,014.5 | 59.8 |
| Employees | 311 | 10,800 | 210 |
| Market Cap ($ mil.) | 57.3 | 2,208.5 | -- |
Competitive Landscape
